Our research is focused on biophysics and drug discovery of estrogen receptor (ER), a key driver for breast cancer growth.
We have established an integrative multi-technique iSPOT platform for structure determination of protein-protein complexes.
The application of iSPOT has uncovered a long-standing mystery about the inner-workings to the ER, critical for understanding the signaling from hormone activation to DNA binding.
Another area of focus is placed on protein folding of an intrinsically-disordered domain of the ER, responsible uniquely for cancer activation.
Our research benefits from excellent resources to which we have access, and close collaboration with laboratories here at Cleveland and other parts of the globe.
Aug. 17, 2016: Good news on additional funds from the NIH! Many thanks!